IBA – Transparency Notification
21 Décembre 2023 - 6:00PM
IBA – Transparency Notification
(Article 14, paragraph 1 of the law of 2
May 2007 on the disclosure of major holdings)
Louvain-la-Neuve, Belgium, December 21,
2023 18:00
Summary of the notification
IBA (Ion Beam Applications), the world’s leading
provider of proton therapy solutions for the treatment of cancer,
announces that it has to issue a transparency notification, in
accordance with Article 14, al. 1 of the Transparency Law of May 2,
2007 on disclosure of major holdings, further to the notification
received on December 19th 2023.
In its notification, NORGES BANK indicated that
following an acquisition or disposal of securities or voting
rights, its total shareholding in IBA SA had increased and its
shareholding in IBA shares with voting rights had crossed the
threshold of 2% on 15/12/2023.
Content of the notification
- Reason for the notification: Acquisition or disposal of
securities or voting rights
- Notification by: A person notifying alone
- Persons subject to the notification
requirement:
- Date on which the threshold is crossed: 15/12/2023
- Threshold crossed (in %) : 2%
- Denominator : 40.595.290
- Notified details: (extract of the received notification
form)
-
Norges Bank is the central bank of Norway. As part of its central
bank activities, Norges Bank manages Norway's foreign exchange
reservesand is responsible for management of the Norwegian
Government Pension Fund Global (GPFG). The formal responsibility
for managementof the GPFG is placed with the Ministry of Finance,
but is delegated to Norges Bank. All investments are executed by
Norges Bank acting asprincipal and all holdings are registered in
the name of Norges Bank. About IBA IBA (Ion Beam
Applications S.A.) is the world leader in particle accelerator
technology. The company is the leading supplier of equipment and
services in the field of proton therapy, considered to be the most
advanced form of radiation therapy available today. IBA is also a
leading player in the fields of industrial sterilization,
radiopharmaceuticals and dosimetry. The company, based in
Louvain-la-Neuve, Belgium, employs approximately 2.000 people
worldwide. IBA is a certified B Corporation (B Corp) meeting the
highest standards of verified social and environmental performance.
IBA is listed on the pan-European stock exchange EURONEXT (IBA:
Reuters IBAB.BR and Bloomberg IBAB.BB).More information can be
found at: www.iba-worldwide.com For further information,
please contact: Valérie Van
ImpeParalegal
+32479267809legal@iba-group.com
- 20231221-IBA-Norges Bank_transparency EN
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024